InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Topsoe Jakob Haldor, Director. Insider active across 1 company, notably IGM Biosciences, Inc.. In total, 21 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €164k. Activity tracked since 30 June 2021. The latest transaction was filed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations21 total
828 shares0Common StockSEC:0001415889-25-009780:0
1,734 shares0Common StockSEC:0001415889-25-000611:0
1,734 shares0Common StockSEC:0001415889-24-024536:0
1,734 shares0Common StockSEC:0001415889-24-019059:0
1,734 shares0Common StockSEC:0001415889-24-009855:0
492 shares0Common StockSEC:0001209191-24-000522:0
492 shares0Common StockSEC:0001209191-23-051742:0
3,500 shares@ US$9.09917.8% of flowCommon StockSEC:0001209191-23-040700:0
Canonical exit: 27 Sept 2023 (T+90)
492 shares0Common StockSEC:0001209191-23-022984:0
230 shares0Common StockSEC:0001209191-23-001124:0
230 shares0Common StockSEC:0001209191-22-051988:0
230 shares0Common StockSEC:0001209191-22-040892:0
1,481 shares@ US$16.0016.6% of flowCommon StockSEC:0001209191-22-031672:0
Canonical exit: 18 Aug 2022 (T+90)
8,254 shares@ US$14.173883.4% of flowCommon StockSEC:0001209191-22-029240:0
Canonical exit: 10 Aug 2022 (T+90)
230 shares0Common StockSEC:0001209191-22-022719:0
130 shares0Common StockSEC:0001209191-22-001242
130 shares0Common StockSEC:0001209191-22-001242:0
130 shares0Common StockSEC:0001209191-21-059188:0
130 shares0Common StockSEC:0001209191-21-059188
130 shares0Common StockSEC:0001209191-21-045196
130 shares0Common StockSEC:0001209191-21-045196:0
21 of 21 declarations
About Topsoe Jakob Haldor
Jakob Haldor Topsoe is a Director at IGM Biosciences, Inc. In this role, he contributes to the governance of the company, which is active in the biopharmaceutical sector. Mr. Topsoe plays a key role in strategic decision-making and oversight of operations.
